Bristol Myers Squibb BMY has strengthened its near-term outlook following robust fourth-quarter 2025 results reported on Feb. 5, 2026. The stock rose 7.6% post-earnings, closing at $61.99 on Feb. 6 — ...

Bristol Myers Squibb Company (NYSE:BMY) is one of the most undervalued large cap stocks to invest in now. On January 28, Piper Sandler raised its price target for Bristol Myers to $66 from $62, ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best inexpensive stocks to buy now. On January 20, Bristol Myers Squibb announced a partnership with Microsoft (NASDAQ:MSFT) to enhance the early ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Welcome to Bristol-Myers Squibb Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded. I would now like to turn the conference over to Chuck ...

Bristol-Myers Squibb (BMY) added ~2% in the premarket on Thursday after the New Jersey-based pharma giant reported better-than-expected Q4 2025 financials and set its 2026 outlook ahead of consensus ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Most Profitable Undervalued Stocks to Buy On February 6, 2026, Guggenheim raised its price target on Bristol-Myers Squibb Company (NYSE ...

Financial giants have made a conspicuous bullish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb (NYSE:BMY) revealed 9 unusual trades. Delving into the details, ...

Bristol-Myers Squibb Company (NYSE: BMY) is volatile on Wednesday as investors position ahead of its quarterly earnings release. • What are BMY shares currently doing? The drugmaker also expanded a ...